Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP658269.RA9gnfGe_eBne_xyxe8swRxXej1x2AMsefnhsYSvqMmuA130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP658269.RA9gnfGe_eBne_xyxe8swRxXej1x2AMsefnhsYSvqMmuA130_assertion type Assertion NP658269.RA9gnfGe_eBne_xyxe8swRxXej1x2AMsefnhsYSvqMmuA130_head.
- NP658269.RA9gnfGe_eBne_xyxe8swRxXej1x2AMsefnhsYSvqMmuA130_assertion description "[Altogether, these data not only demonstrate that berberine is an important agent against diabetic nephropathy through inhibition of SphK1/AP-1 pathway, but also indicate that the inhibition of SphK1/AP-1 by berberine is independent of ambient glucose concentration.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP658269.RA9gnfGe_eBne_xyxe8swRxXej1x2AMsefnhsYSvqMmuA130_provenance.
- NP658269.RA9gnfGe_eBne_xyxe8swRxXej1x2AMsefnhsYSvqMmuA130_assertion evidence source_evidence_literature NP658269.RA9gnfGe_eBne_xyxe8swRxXej1x2AMsefnhsYSvqMmuA130_provenance.
- NP658269.RA9gnfGe_eBne_xyxe8swRxXej1x2AMsefnhsYSvqMmuA130_assertion SIO_000772 23085271 NP658269.RA9gnfGe_eBne_xyxe8swRxXej1x2AMsefnhsYSvqMmuA130_provenance.
- NP658269.RA9gnfGe_eBne_xyxe8swRxXej1x2AMsefnhsYSvqMmuA130_assertion wasDerivedFrom befree-20140225 NP658269.RA9gnfGe_eBne_xyxe8swRxXej1x2AMsefnhsYSvqMmuA130_provenance.
- NP658269.RA9gnfGe_eBne_xyxe8swRxXej1x2AMsefnhsYSvqMmuA130_assertion wasGeneratedBy ECO_0000203 NP658269.RA9gnfGe_eBne_xyxe8swRxXej1x2AMsefnhsYSvqMmuA130_provenance.